Dipna Pharmachem [DPL] vs Medplus Health [MEDPLUS] Detailed Stock Comparison

Dipna Pharmachem

BSE

Medplus Health

NSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Dipna Pharmachem wins in 10 metrics, Medplus Health wins in 8 metrics, with 0 ties. Dipna Pharmachem appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Dipna Pharmachem	Medplus Health	Better
P/E Ratio (TTM)	55.73	72.95	Dipna Pharmachem
Price-to-Book Ratio	1.39	6.22	Dipna Pharmachem
Debt-to-Equity Ratio	44.74	64.36	Dipna Pharmachem
PEG Ratio	N/A	60.26	N/A
EV/EBITDA	20.51	36.83	Dipna Pharmachem
Profit Margin (TTM)	0.78%	2.45%	Medplus Health
Operating Margin (TTM)	5.69%	4.78%	Dipna Pharmachem
EBITDA Margin (TTM)	5.69%	4.78%	Dipna Pharmachem
Return on Equity	2.56%	9.06%	Medplus Health
Return on Assets (TTM)	1.61%	4.66%	Medplus Health
Free Cash Flow (TTM)	$-92.15M	$4.81B	Medplus Health
Dividend Yield	23.16%	N/A	N/A
1-Year Return	-94.60%	38.77%	Medplus Health
Price-to-Sales Ratio (TTM)	0.45	1.78	Dipna Pharmachem
Enterprise Value	$704.19M	$115.79B	Medplus Health
EV/Revenue Ratio	0.56	1.89	Dipna Pharmachem
Gross Profit Margin (TTM)	44.45%	26.56%	Dipna Pharmachem
Revenue per Share (TTM)	$53	$513	Medplus Health
Earnings per Share (Diluted)	$0.41	$12.49	Medplus Health
Beta (Stock Volatility)	-0.21	0.68	Dipna Pharmachem

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Dipna Pharmachem vs Medplus Health Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Dipna Pharmachem	-0.17%	-1.90%	5.17%	5.78%	74.72%	62.99%
Medplus Health	2.56%	5.66%	3.31%	15.92%	27.58%	10.13%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Dipna Pharmachem	-94.60%	-88.33%	-54.14%	-78.61%	-79.07%	-79.07%
Medplus Health	38.77%	26.40%	-13.16%	-13.16%	-13.16%	-13.16%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Dipna Pharmachem (DPL): View Full Stock Overview

Medplus Health (MEDPLUS): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Dipna Pharmachem vs Medplus Health

Metric	DPL	MEDPLUS
Market Information
Market Cap i	₹564.97M	₹109.05B
Market Cap Category	Small cap	Mid cap
10 Day Avg. Volume i	44,400	114,654
90 Day Avg. Volume i	82,700	131,605
Last Close	₹23.78	₹934.45
52 Week Range	₹11.45 - ₹542.55	₹616.00 - ₹1,045.30
% from 52W High	-95.62%	-10.60%
All-Time High	₹558.00 (Jan 29, 2024)	₹1,343.00 (Jan 17, 2022)
% from All-Time High	-95.74%	-30.42%
Growth Metrics
Quarterly Revenue Growth	-0.62%	0.01%
Quarterly Earnings Growth	0.29%	0.54%
Financial Health
Profit Margin (TTM) i	0.01%	0.02%
Operating Margin (TTM) i	0.06%	0.05%
Return on Equity (TTM) i	0.03%	0.09%
Debt to Equity (MRQ) i	44.74	64.36
Cash & Liquidity
Book Value per Share (MRQ)	₹16.40	₹146.47
Cash per Share (MRQ)	₹0.18	₹30.90
Operating Cash Flow (TTM) i	₹-91,946,000	₹5.40B
Levered Free Cash Flow (TTM) i	₹-123,409,000	₹3.62B
Dividends
Last 12-Month Dividend Yield i	23.16%	N/A
Last 12-Month Dividend i	₹5.00	N/A

Valuation & Enterprise Metrics Analysis: Dipna Pharmachem vs Medplus Health

Metric	DPL	MEDPLUS
Price Ratios
P/E Ratio (TTM) i	55.73	72.95
Forward P/E i	N/A	60.26
PEG Ratio i	N/A	60.26
Price to Sales (TTM) i	0.45	1.78
Price to Book (MRQ) i	1.39	6.22
Market Capitalization
Market Capitalization i	₹564.97M	₹109.05B
Enterprise Value i	₹704.19M	₹115.79B
Enterprise Value Metrics
Enterprise to Revenue i	0.56	1.89
Enterprise to EBITDA i	20.51	36.83
Risk & Other Metrics
Beta i	-0.21	0.68
Book Value per Share (MRQ) i	₹16.40	₹146.47

Financial Statements Comparison: Dipna Pharmachem vs Medplus Health

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	DPL	MEDPLUS
Revenue/Sales i	₹1.48B	₹15.10B
Cost of Goods Sold i	₹823.75M	₹11.09B
Gross Profit i	₹659.26M	₹4.01B
Research & Development i	N/A	N/A
Operating Income (EBIT) i	₹362.82M	₹721.66M
EBITDA i	₹1.44B	₹1.52B
Pre-Tax Income i	₹1.13B	₹611.16M
Income Tax i	₹455.55M	₹97.96M
Net Income (Profit) i	₹676.72M	₹513.20M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	DPL	MEDPLUS
Cash & Equivalents i	₹4.26M	₹860.52M
Total Current Assets i	₹1.32B	₹18.44B
Total Current Liabilities i	₹849.96M	₹5.77B
Long-Term Debt i	₹88.90M	₹10.08B
Total Shareholders Equity i	₹384.93M	₹17.40B
Retained Earnings i	N/A	N/A
Property, Plant & Equipment i	₹459,000	₹12.49B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	DPL	MEDPLUS
Operating Cash Flow i	N/A	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	N/A	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	DPL	MEDPLUS
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	44,400	114,654
Average Daily Volume (90 Day) i	82,700	131,605
Shares Outstanding i	24.05M	119.64M
Float Shares i	7.91M	68.65M
% Held by Insiders i	0.45%	0.42%
% Held by Institutions i	0.00%	0.34%

Dividend Analysis & Yield Comparison: Dipna Pharmachem vs Medplus Health

Metric	DPL	MEDPLUS
Last 12-Month Dividend i	₹5.00	N/A
Last 12-Month Dividend Yield i	23.16%	N/A
3-Year Avg Annual Dividend i	₹6.00	N/A
3-Year Avg Dividend Yield i	1.72%	N/A
3-Year Total Dividends i	₹18.00	N/A
Ex-Dividend Date	Aug 13, 2024	N/A

Dipna Pharmachem [DPL] vs Medplus Health [MEDPLUS] Detailed Stock Comparison